Increasing Insulin Pump Use in Youth with Type 1 Diabetes While Addressing Disparities.
- 1From the Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
- 2Department of Clinical Nutrition, UW Health, Madison, Wis.
- 3Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, UW Health Kids, Madison, Wis.
Abstract
Automated insulin delivery is recommended for youth with type 1 diabetes (T1D). We aimed to increase the percentage of youth with T1D (diagnosed > 1 y) in 1 pediatric health system actively using an insulin pump from 56% to 65% within 18 months while reducing disparities based on race/ethnicity and insurance type. Following the Model for Improvement, local stakeholders organized this quality improvement project, identified a theory of change, and tested change ideas using the plan-do-study-act framework. We evaluated the primary outcome with a statistical process control chart, secondary outcomes with run charts, and other measures with descriptive statistics. Between February 2024 and August 2025, insulin pump use increased from 56% to 65%, but disparities by race/ethnicity and insurance type persisted. Time from insulin pump education to initiation decreased by 19.8 days for patients who attended a group technology class. Non-face-to-face encounter volume decreased from 938 to 862 encounters per month, and diabetes-associated ketoacidosis events remained stable at 2% per month. This initiative increased insulin pump use among both reference and minoritized groups of youth with T1D at a single institution and improved the efficiency of the insulin pump initiation process without a measurable increase in workload or diabetes-associated ketoacidosis events. Although increased pump adoption among both groups is encouraging, continued advocacy at the individual and policy levels is needed to achieve optimal pump use and reduce disparities.
Related
- ACCESS2 study: the potential for autonomous AI to mitigate disparities in diabetic retinopathy screening in youth
- The prevalence of type 2 diabetes mellitus among people with amyotrophic lateral sclerosis is increasing in the United States
- Temporal trends and regional disparities in costs and affordability of non-insulin antidiabetic drugs in China, 2015–2022: a retrospective observational study
- Age-sex-income triad disparities in diet-attributable diabetes: a GBD 2023 analysis reveals East Asia and Pacific region's decoupling phenomenon and cost-effective solutions.
- Balancing clinical benefits and behavioral risks of obesity-focused management in youth-onset type 2 diabetes: A narrative review
BibTeX
@article{vidmar2026increasing,
title = {{Increasing Insulin Pump Use in Youth with Type 1 Diabetes While Addressing Disparities.}},
author = {Kimberly K Vidmar and Rachel J Fenske and Whitney Beaton and M Tracy Bekx and Elizabeth A Mann},
journal = {Pediatric quality \& safety},
year = {2026},
month = oct,
doi = {10.1097/pq9.0000000000000946},
url = {https://europepmc.org/article/MED/42953609},
note = {CC BY},
}
RIS
TY - JOUR
TI - Increasing Insulin Pump Use in Youth with Type 1 Diabetes While Addressing Disparities.
AU - Kimberly K Vidmar
AU - Rachel J Fenske
AU - Whitney Beaton
AU - M Tracy Bekx
AU - Elizabeth A Mann
PY - 2026
DA - 2026/10/28
JO - Pediatric quality & safety
DO - 10.1097/pq9.0000000000000946
UR - https://europepmc.org/article/MED/42953609
AB - Automated insulin delivery is recommended for youth with type 1 diabetes (T1D). We aimed to increase the percentage of youth with T1D (diagnosed > 1 y) in 1 pediatric health system actively using an insulin pump from 56% to 65% within 18 months while reducing disparities based on race/ethnicity and insurance type. Following the Model for Improvement, local stakeholders organized this quality improvement project, identified a theory of change, and tested change ideas using the plan-do-study-act framework. We evaluated the primary outcome with a statistical process control chart, secondary outcomes with run charts, and other measures with descriptive statistics. Between February 2024 and August 2025, insulin pump use increased from 56% to 65%, but disparities by race/ethnicity and insurance type persisted. Time from insulin pump education to initiation decreased by 19.8 days for patients who attended a group technology class. Non-face-to-face encounter volume decreased from 938 to 862 encounters per month, and diabetes-associated ketoacidosis events remained stable at 2% per month. This initiative increased insulin pump use among both reference and minoritized groups of youth with T1D at a single institution and improved the efficiency of the insulin pump initiation process without a measurable increase in workload or diabetes-associated ketoacidosis events. Although increased pump adoption among both groups is encouraging, continued advocacy at the individual and policy levels is needed to achieve optimal pump use and reduce disparities.
SN - 2472-0054
ER -